UY34667A - ?método y dispositivo para el tratamiento de trastornos del colesterol en la sangre?. - Google Patents

?método y dispositivo para el tratamiento de trastornos del colesterol en la sangre?.

Info

Publication number
UY34667A
UY34667A UY0001034667A UY34667A UY34667A UY 34667 A UY34667 A UY 34667A UY 0001034667 A UY0001034667 A UY 0001034667A UY 34667 A UY34667 A UY 34667A UY 34667 A UY34667 A UY 34667A
Authority
UY
Uruguay
Prior art keywords
blood
treatment
cholesterol disorders
cholesterol
disorders
Prior art date
Application number
UY0001034667A
Other languages
English (en)
Inventor
Victor Grifols Lucas
Victor Grifols Roura
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of UY34667A publication Critical patent/UY34667A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/12—Blood circulatory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un sistema, método y dispositivo para el tratamiento de trastornos del colesterol a un paciente que tiene niveles de colesterol total anormales, niveles de LDL anormales y/o niveles de HDL anormales antes del tratamiento; uso de células de sangre total separadas del plasma, en el tratamiento de la hipercolesterolemia y otros transtornos del colesterol en sangre
UY0001034667A 2012-03-12 2013-03-11 ?método y dispositivo para el tratamiento de trastornos del colesterol en la sangre?. UY34667A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/418,123 US10624924B2 (en) 2012-03-12 2012-03-12 Method and device for treating blood cholesterol disorders

Publications (1)

Publication Number Publication Date
UY34667A true UY34667A (es) 2013-10-31

Family

ID=47891413

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034667A UY34667A (es) 2012-03-12 2013-03-11 ?método y dispositivo para el tratamiento de trastornos del colesterol en la sangre?.

Country Status (24)

Country Link
US (1) US10624924B2 (es)
EP (1) EP2638918B1 (es)
JP (1) JP6218401B2 (es)
KR (2) KR20130105452A (es)
CN (2) CN103301520A (es)
AR (1) AR090295A1 (es)
AU (1) AU2013201550B2 (es)
BR (1) BR102013005877B1 (es)
CA (1) CA2809012C (es)
CL (1) CL2013000667A1 (es)
ES (1) ES2598241T3 (es)
HK (1) HK1185791A1 (es)
HU (1) HUE029681T2 (es)
IL (1) IL225129A (es)
MX (1) MX344112B (es)
MY (1) MY169320A (es)
NZ (1) NZ608133A (es)
PL (1) PL2638918T3 (es)
PT (1) PT2638918T (es)
RU (1) RU2625774C2 (es)
SG (1) SG193729A1 (es)
TW (1) TWI554275B (es)
UY (1) UY34667A (es)
ZA (1) ZA201301815B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10624924B2 (en) 2012-03-12 2020-04-21 Grifols, S.A. Method and device for treating blood cholesterol disorders
AU2015201496B2 (en) * 2014-06-03 2019-10-31 Grifols Worldwide Operations Limited Use of plasmapheresis to treat blood pressure disorders

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374731A (en) 1980-03-06 1983-02-22 Baxter Travenol Laboratories, Inc. Method and apparatus for obtaining a desired rate of plasma collection from a membrane plasmapheresis filter
US4350156A (en) 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
US4540401A (en) * 1983-02-22 1985-09-10 Applied Immune Sciences, Inc. In vivo therapeutic apheresis using lipid vesicles
JPH0657250B2 (ja) 1984-06-29 1994-08-03 バクスター・インターナショナル・インコーポレーテッド 血液抽出及び再注輸の血流制御装置
US5258149A (en) 1990-11-27 1993-11-02 W. R. Grace & Co.-Conn. Process of making a membrane for high efficiency removal of low density lipoprotein-cholesterol from whole blood
CA2095424A1 (en) 1992-05-14 1993-11-15 Marc Ellous Parham Microporous polysulfone support suitable for removal of low density lipoprotein-cholesterol
JPH06254152A (ja) * 1993-03-03 1994-09-13 Terumo Corp 血漿交換装置
JPH0788179A (ja) * 1993-09-22 1995-04-04 Terumo Corp 血漿交換装置
RU2113240C1 (ru) 1995-05-05 1998-06-20 Акционерное общество закрытого типа "Оптика" Способ мембранного плазмафереза по одноигольной схеме под действием силы тяжести и устройство для его осуществления
WO1996037602A1 (en) 1995-05-26 1996-11-28 Diacrin, Inc. Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function
US5846427A (en) 1995-10-23 1998-12-08 Hemasure, Inc. Extra-lumenal crossflow plasmapheresis devices and method of use thereof
FR2747591B1 (fr) 1996-04-19 1998-05-22 Hospal Ind Appareil medical pour le traitement extracorporel du sang ou du plasma et procedes de fabrication de cet appareil
EP0938504A2 (en) * 1996-06-07 1999-09-01 Eli Lilly And Company Ob PROTEIN BINDING PROTEIN
US6627151B1 (en) 1997-06-13 2003-09-30 Helmut Borberg Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion
RU2153168C2 (ru) * 1997-11-25 2000-07-20 Научно-исследовательский институт кардиологии Способ определения показаний к проведению плазмафереза при лечении стенокардии
DE19821534C1 (de) 1998-05-14 1999-08-19 Braun Melsungen Ag Blutreinigungsmaschine
JP2002533169A (ja) 1998-12-29 2002-10-08 オキュロジックス コーポレイション レオロジー的処置方法および関連するアフェレーシスシステム
ATE316391T1 (de) 1999-04-30 2006-02-15 Childrens Hosp Medical Center Hämofiltrationssystem
RU2195321C2 (ru) 2000-11-16 2002-12-27 Государственный научно-клинический центр охраны здоровья шахтеров Способ лечения церебрального атеросклероза
US6991727B2 (en) 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US6982038B2 (en) * 2002-06-14 2006-01-03 Medtronic, Inc. Centrifuge system utilizing disposable components and automated processing of blood to collect platelet rich plasma
US20040102732A1 (en) 2002-06-19 2004-05-27 Morteza Naghavi Dialysis system for treatment of vulnerable patients and methods of use
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
ES2715496T3 (es) * 2003-07-03 2019-06-04 Hdl Therapeutics Inc Métodos y aparatos para crear derivados de partículas de HDL con un contenido reducido de lípidos
US20050051497A1 (en) 2003-07-31 2005-03-10 Latino Joseph S. Viral inactivation using ozone
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US8038638B2 (en) 2004-02-23 2011-10-18 Hemolife Medical, Inc. Plasma detoxification and volume control system and methods of use
DE102004054747A1 (de) 2004-11-12 2006-05-24 Fresenius Medical Care Deutschland Gmbh Verfahren und Vorrichtung zur Abreicherung wenigstens einer Komponente eines fluiden Mediums
WO2007019519A2 (en) 2005-08-05 2007-02-15 National Quality Care, Inc. Dual-channel pump cartridge and pump for dialysis use
RU2310478C1 (ru) 2006-05-03 2007-11-20 Александр Георгиевич Рожков Способ лечения атеросклероза
GB0621452D0 (en) 2006-10-27 2006-12-06 Ucl Business Plc Therapy for liver disease
CN100500229C (zh) 2006-12-29 2009-06-17 上海达华医疗器械有限公司 一种多功能体外血液治疗仪
FR2911417B1 (fr) 2007-01-17 2009-02-27 Gambro Lundia Ab Suivi de l'acces vasculaire d'un patient soumis a des seances successives de traitement extracorporel de sang
US20120165685A1 (en) 2010-12-22 2012-06-28 Weasler Marc N Plasmapheresis donor display and method of use
CN201006071Y (zh) 2007-02-13 2008-01-16 沈建华 一种智能输液泵
US8409441B2 (en) 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
CA2747557A1 (en) 2008-12-19 2010-06-24 Anthera Pharmaceuticals, Inc. Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies
WO2011015380A1 (en) 2009-08-05 2011-02-10 Celltrend Gmbh Method for prognosis of pulmonary arterial hypertension by detecting anti-par2-antibodies
JP5822836B2 (ja) 2009-10-08 2015-11-24 大塚製薬株式会社 悪性腫瘍の治療のための免疫活性化血液灌流フィルタ
WO2011080191A1 (en) 2009-12-28 2011-07-07 Gambro Lundia Ab Monitoring blood pressure
CA3012773C (en) 2010-10-19 2022-05-03 L&F Research Llc Assays, methods and kits for predicting renal disease and personalized treatment strategies
ES2683953T3 (es) 2011-02-07 2018-09-28 Aggamin Llc Procedimientos y sistemas para tratar o prevenir trastornos hipertensivos gestacionales
US10624924B2 (en) 2012-03-12 2020-04-21 Grifols, S.A. Method and device for treating blood cholesterol disorders

Also Published As

Publication number Publication date
AU2013201550B2 (en) 2015-07-02
CN107754038A (zh) 2018-03-06
AR090295A1 (es) 2014-11-05
TWI554275B (zh) 2016-10-21
US10624924B2 (en) 2020-04-21
CN103301520A (zh) 2013-09-18
MX344112B (es) 2016-11-30
KR101908899B1 (ko) 2018-10-16
CL2013000667A1 (es) 2013-07-12
BR102013005877A2 (pt) 2017-07-11
PT2638918T (pt) 2016-10-24
AU2013201550A1 (en) 2013-09-26
KR20130105452A (ko) 2013-09-25
EP2638918B1 (en) 2016-08-31
EP2638918A1 (en) 2013-09-18
HUE029681T2 (en) 2017-02-28
CA2809012A1 (en) 2013-09-12
JP2013188475A (ja) 2013-09-26
US20130236559A1 (en) 2013-09-12
HK1185791A1 (zh) 2014-02-28
RU2013110503A (ru) 2014-09-20
PL2638918T3 (pl) 2017-01-31
MY169320A (en) 2019-03-21
IL225129A (en) 2017-02-28
ZA201301815B (en) 2013-11-27
ES2598241T3 (es) 2017-01-26
BR102013005877B1 (pt) 2021-10-26
IL225129A0 (en) 2013-06-27
TW201340973A (zh) 2013-10-16
KR20180074646A (ko) 2018-07-03
JP6218401B2 (ja) 2017-10-25
CA2809012C (en) 2020-04-14
NZ608133A (en) 2014-09-26
SG193729A1 (en) 2013-10-30
RU2625774C2 (ru) 2017-07-18
MX2013002681A (es) 2013-09-12

Similar Documents

Publication Publication Date Title
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
BR112014028417A2 (pt) aparelho de terapia de ferimentos por pressão negativa.
CR20150046A (es) Anticuerpos anti-cd79b e inmunoconjugados
BR112015007494A2 (pt) aparelho para tratamento dentário.
CR20150047A (es) Anticuerpos anti-cd22 e inmunoconjugados
PH12014501844A1 (en) Peptidomimetic macrocycles
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
EA201790575A1 (ru) Триазолопиразиноны в качестве ингибиторов pde1
DK2877184T3 (da) Sammensætninger og behandling for øjensygdomme og -lidelser
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DE102012104039A8 (de) Hubtoranordnung sowie Torsturz-Abdichteinrichtung hierfür
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
CL2015000926A1 (es) Proceso para la elaboración de compuestos para el tratamiento del cancer derivados de azetidin-1-il-metanona y compuestos intermediarios.
BR112015014952A2 (pt) homogeneizador de alta pressão e processo de homogeneização
BR112014016937A2 (pt) terapia de combinação para o tratamento de desordens de audição e do equilíbrio
BR112014030159A2 (pt) agente para tratamento de floculação.
CO7151543A2 (es) Combinaciones terapéuticas y métodos para tratar el melanoma
AU350280S (en) Apparatus for skin treatment
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
UY34575A (es) Composiciones y métodos para el tratamiento de diabetes y/u obesidad
EA201691108A1 (ru) Хиназолин-thf-амины в качестве ингибиторов pde1
UY34609A (es) Motivos de interacción de transactivación en plantas y sus usos
ITRM20120530A1 (it) Compounds for use in the treatment of parasitic diseases
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
BR112015002867A2 (pt) dispositivos e métodos para fixar dispositivos médicos dentro de uma anatomia.

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20220126